44 related articles for article (PubMed ID: 10352197)
1. Ultrasound-Guided Radiofrequency Ablation in Tertiary Hyperparathyroidism: A Prospective Study.
Deng E; Jiang T; Chai H; Weng N; He H; Zhang Z; Peng C; Yue W; Xu H
Korean J Radiol; 2024 Mar; 25(3):289-300. PubMed ID: 38413113
[TBL] [Abstract][Full Text] [Related]
2. Ethanol ablation of thyroid cysts in the young with a focus on efficacy and quality of life.
Halenka M; Munteanu H; Obereigneru R; Dohnal R; Karasek D; Schovanek J
Eur Thyroid J; 2023 Aug; 12(5):. PubMed ID: 37432713
[TBL] [Abstract][Full Text] [Related]
3. Effects of percutaneous ethanol injection therapy on subsequent surgical parathyroidectomy.
Nakamura M; Marui Y; Ubara Y; Nakanishi S; Takemoto F; Takaichi K; Tomikawa S
NDT Plus; 2008 Aug; 1(Suppl 3):iii39-iii41. PubMed ID: 25983972
[TBL] [Abstract][Full Text] [Related]
4. Current status of parathyroidectomy for secondary hyperparathyroidism in Japan.
Tominaga Y
NDT Plus; 2008 Aug; 1(Suppl 3):iii35-iii38. PubMed ID: 25983971
[No Abstract] [Full Text] [Related]
5. Long-term prognosis of parathyroid function in chronic dialysis patients after PEIT-a single-centre trial.
Tanaka R; Kakuta T; Koiwa F; Fukagawa M; Saito A
NDT Plus; 2008 Aug; 1(Suppl 3):iii29-iii34. PubMed ID: 25983970
[TBL] [Abstract][Full Text] [Related]
6. New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients.
Onoda N; Fukagawa M; Tominaga Y; Kitaoka M; Akizawa T; Koiwa F; Kakuta T; Kurokawa K;
NDT Plus; 2008 Aug; 1(Suppl 3):iii26-iii28. PubMed ID: 25983969
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention.
Kakuta T; Fukagawa M; Kitaoka M; Koiwa F; Onoda N; Tominaga Y; Akizawa T; Kurokawa K;
NDT Plus; 2008 Aug; 1(Suppl 3):iii21-iii25. PubMed ID: 25983968
[TBL] [Abstract][Full Text] [Related]
8. Medical management after parathyroid intervention.
Tanaka M; Fukagawa M
NDT Plus; 2008 Aug; 1(Suppl 3):iii18-iii20. PubMed ID: 25983966
[TBL] [Abstract][Full Text] [Related]
9. Indication and efficacy of PEIT in the management of secondary hyperparathyroidism.
Koiwa F; Hasegawa T; Tanaka R; Kakuta T
NDT Plus; 2008 Aug; 1(Suppl 3):iii14-iii17. PubMed ID: 25983965
[TBL] [Abstract][Full Text] [Related]
10. Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.
Tominaga Y; Matsuoka S; Uno N
World J Surg; 2009 Nov; 33(11):2335-42. PubMed ID: 19247704
[TBL] [Abstract][Full Text] [Related]
11. The kidney and bone metabolism: Nephrologists' point of view.
Fukagawa M; Hamada Y; Nakanishi S; Tanaka M
J Bone Miner Metab; 2006; 24(6):434-8. PubMed ID: 17072734
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.
Klaus G; Watson A; Edefonti A; Fischbach M; Rönnholm K; Schaefer F; Simkova E; Stefanidis CJ; Strazdins V; Vande Walle J; Schröder C; Zurowska A; Ekim M;
Pediatr Nephrol; 2006 Feb; 21(2):151-9. PubMed ID: 16247644
[TBL] [Abstract][Full Text] [Related]
13. Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment.
Sanchez CP
Paediatr Drugs; 2003; 5(11):763-76. PubMed ID: 14580225
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognosis of parathyroid function after successful percutaneous ethanol injection therapy (PEIT) guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Kunimatsu K; Tadaki F; Fujisaki T; Noguchi M; Abe Y; Sakai H; Kurokawa K; Saito A
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():60s-65s. PubMed ID: 10914993
[TBL] [Abstract][Full Text] [Related]
16. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
[TBL] [Abstract][Full Text] [Related]
17. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
Uemura K; Kakuta T
Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
Koiwa F; Kakuta T; Tanaka R; Yumita S
Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
